The use of four-factor prothrombin complex concentrate in patients with liver disease on warfarin therapy

被引：2
|
作者：
Stevens, Craig A. [1 ]
Yau, Benny C. [2 ]
Lai, Ngan C. [3 ]
Huang, Wan-Ting [1 ]
Cang, William C. [1 ]
Bushway, Audrey [1 ]
Derry, Katrina L. [1 ]
机构：
[1] UC San Diego Hlth, Dept Pharm, San Diego, CA USA
[2] Stanford Hlth Care, Dept Pharm, Stanford, CA USA
[3] Sutter Hlth Care, Dept Pharm, Oakland, CA USA
来源：
THROMBOSIS RESEARCH | 2021年 / 204卷
关键词：
COAGULOPATHY; PROTECT;
D O I：
10.1016/j.thromres.2021.06.013
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：123 / 125
页数：3
相关论文
共 50 条
  • [11] Four-factor prothrombin complex concentrate dose response relationship with INR for warfarin reversal
    Yohe, Alexander S.
    Livings, Sarah E.
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2019, 37 (08): : 1534 - 1538
  • [12] CHARACTERIZATION OF FOUR-FACTOR PROTHROMBIN COMPLEX CONCENTRATE USE AT A COMMUNITY HOSPITAL
    Teevan, Colleen
    Musial, Bogdan
    CRITICAL CARE MEDICINE, 2016, 44 (12)
  • [13] Evaluation of modified fixed dose four-factor prothrombin complex concentrate for warfarin reversal
    Peterson, Meghan E.
    Jaynes, Megan P.
    Berardi, Sarah
    Morton, Colleen
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2024, 57 (05) : 865 - 870
  • [14] USE OF FOUR-FACTOR PROTHROMBIN COMPLEX CONCENTRATE IN THE EMERGENCY DEPARTMENT: A REVIEW
    Willis, Courtney M.
    Hall, A. Brad
    JOURNAL OF EMERGENCY NURSING, 2015, 41 (01) : 9 - 12
  • [15] EFFECTIVENESS AND SAFETY OF FOUR-FACTOR PROTHROMBIN COMPLEX CONCENTRATE IN CIRRHOTIC PATIENTS
    Johnson, Audrey
    Aberle, Caitlin
    Papadopoulos, John
    Esaian, Diana
    CRITICAL CARE MEDICINE, 2015, 43 (12)
  • [16] Four-Factor Prothrombin Complex Concentrate for Patients With Trauma-Reply
    Bouzat, Pierre
    Gauss, Tobias
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (09): : 876 - 876
  • [17] THROMBOEMBOLIC RISK OF FOUR-FACTOR PROTHROMBIN COMPLEX CONCENTRATE IN CANCER PATIENTS
    Akella, Padmastuti
    Tao, Jing
    Pastores, Stephen
    CRITICAL CARE MEDICINE, 2022, 50 (01) : 313 - 313
  • [18] EVALUATION OF MODIFIED FIXED-DOSE FOUR-FACTOR PROTHROMBIN COMPLEX CONCENTRATE FOR WARFARIN REVERSAL
    Peterson, Meghan
    Jaynes, Megan
    Berardi, Sarah
    Morton, Colleen
    CRITICAL CARE MEDICINE, 2024, 52
  • [19] COST ADVANTAGE OF FIXED-DOSE FOUR-FACTOR PROTHROMBIN COMPLEX CONCENTRATE FOR WARFARIN REVERSAL
    Lucarelli, Stefani
    Miller, Kirsten
    Troyer, Camille
    Huang, Wan-Ting
    Park, Jung Hoon
    CRITICAL CARE MEDICINE, 2024, 52
  • [20] FIXED-DOSE FOUR-FACTOR PROTHROMBIN COMPLEX CONCENTRATE IN WARFARIN AND FACTOR XA INHIBITOR REVERSAL
    Kim, Ji-Yeon
    Berg-Lewis, David
    Amoateng, Ricky
    CRITICAL CARE MEDICINE, 2024, 52
12345